Brief: Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator
BRIEF-Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator June 18 (Reuters) - SK Inc 034730.KS:
SK PHARMTECO ANNOUNCES STRATEGIC COLLABORATION WITH ORPHAN THERAPEUTICS ACCELERATOR FOR THE DEVELOPMENT AND MANUFACTURING OF RARE DISEASE THERAPIES
Source text: ID:nGNX4GVfKP
Further company coverage: 034730.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK
See all newsMedia: SK Data Center Arm in Talks to Fund $350 Billion AI Buildout - Bloomberg News
SK Group Chairman Chey sells stake to Dell family office fund for $406 million
SK's Chey vows to build Gwangju chip plants as fast as possible, no start date set (updated)
South Korea unveils $747 billion energy transition plan through 2035 (updated)
Deals of the day-Mergers and acquisitions